Aridis Pharmaceuticals, Inc. Quarterly Operating Lease, Liability, Current in USD from Q1 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Aridis Pharmaceuticals, Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q1 2022 to Q3 2023.
  • Aridis Pharmaceuticals, Inc. Operating Lease, Liability, Current for the quarter ending September 30, 2023 was $576K, a 9.51% increase year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $576K +$50K +9.51% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $563K +$49K +9.53% Jun 30, 2023 10-Q 2023-09-14
Q1 2023 $550K +$60K +12.2% Mar 31, 2023 10-Q 2023-06-08
Q4 2022 $538K Dec 31, 2022 10-Q 2023-11-06
Q3 2022 $526K Sep 30, 2022 10-K 2023-05-22
Q2 2022 $514K Jun 30, 2022 10-K 2023-05-22
Q1 2022 $490K Mar 31, 2022 10-K 2023-05-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.